1. A method of modulating one or more immunoregulatory cytokines, comprising administering to a subject a therapeutically effective amount of one or more phosphate derivatives of one or more hydroxychromanes or their complexes. ! 2. The method according to claim 1, in which the immunoregulatory cytokine is an inflammatory cytokine or anti-inflammatory cytokine. ! 3. The method according to claim 2, in which the inflammatory cytokine is a cytokine type of interleukin or a cytokine type of tumor necrosis factor. ! 4. The method according to claim 3, in which the cytokine type interleukin is selected from the group consisting of interleukin-1α (IL-1α), interleukin-1β (IL-1β), interleukin-6 (IL-6), interleukin-8 ( IL-8), interleukin-11 (IL-11) and interleukin-18 (IL-18). ! 5. The method according to claim 3, in which the cytokine type of tumor necrosis factor is a tumor necrosis factor-alpha. ! 6. The method of claim 2, wherein the anti-inflammatory cytokine is an interleukin type cytokine, tumor necrosis factor type cytokine, interferon cytokine or growth factor cytokine. ! 7. The method according to claim 6, in which the cytokine type of interleukin is selected from the group consisting of interleukin-4 (IL-4), interleukin-10 (IL-10) and interleukin-13 (IL-13). ! 8. The method according to claim 6, in which the cytokine-interferon is an IFNα. ! 9. The method according to claim 6, in which the cytokine growth factor is a transforming growth factor or colony stimulating factor granulocytes. ! 10. The method according to claim 6, in which the transforming growth factor is TGFβ. ! 11. The method according to claim 6, in which the colony-stimulating factor of granulocytes is G-CSF. ! 12. The method according to claim 1, in which the phosphate derivative of hydroxychroman is selected from
展开▼
